Trials / Sponsors / SwanBio Therapeutics, Inc.
SwanBio Therapeutics, Inc.
Industry · 2 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | A Study to Evaluate Administration of SBT101 Gene Therapy in Adult Patients With Adrenomyeloneuropathy (AMN) AMN, AMN Gene Mutation, X-ALD | Phase 1 / Phase 2 | 2022-11-17 |
| Terminated | Study of Disease Progression in Adults With Inherited Forms of Spastic Paraplegia AMN, AMN Gene Mutation, X-ALD | — | 2021-06-21 |